Subtle UTI Symptoms Women Over 50 Should Never Put Up With
'Leaving a UTI untreated increases the risk of the infection spreading to the kidneys, which can cause permanent damage or even lead to sepsis,' says Uma Darji, MD, a board-certified family medicine physician in Raleigh, NC. That's why it's important to recognize UTI symptoms early. Here we explain who's most at risk, what to watch for and what to do if you suspect you have a UTI.
Women experience UTIs about four times as often as men. This is partly because women have a shorter urethra, which makes it easier for bacteria to reach the bladder. The female urethra is also closer to the anus, where E.coli—the bacteria that causes around 80 percent of UTIs—is often found.
Menopause can increase UTI risk even further. 'In menopause, estrogen levels drop significantly,' says Sara Tariq, MD, an internal medicine physician at Northern Virginia Family Practice. 'As a result, the urethra becomes thinner and drier, making it easier for bacteria on the skin to enter the bladder and cause an infection.' Lower estrogen levels also lead to a decrease in lactobacilli, a protective bacteria in the bladder and vagina that helps to prevent the overgrowth of harmful bacteria, Dr. Tariq adds.
People with diabetes or high blood sugar may be at a high risk for UTIs. According to a review of research published in Diabetes, Metabolic Syndrome and Obesity, people with type 2 diabetes are more likely to get UTIs because sugar in the urine can feed harmful bacteria. Nerve damage from diabetes may also make it difficult to fully empty your bladder, which gives bacteria more time to multiply, increasing the risk of infection.
In addition to being in menopause or having diabetes, sexual activity, holding your urine, dehydration and wiping from back to front can also increase your UTI risk, Dr. Darji says. If any of these risk factors apply to you, it's especially important to be on the lookout for early warning signs of a bladder infection. Some of the most common UTI symptoms include:
Frequent urination
An urgent need to urinate
Pain or burning with urination
Pain in the lower abdomen
Cloudy or foul-smelling urine
If the infection is left untreated and spreads to your kidneys, you may also experience fever or back pain, according to the National Kidney Foundation.
Some women may also have more subtle UTI symptoms that are easy to dismiss to write off as something else. 'Less obvious UTI symptoms include fatigue, pelvic discomfort, a sudden change in mental status or blood in the urine,' Dr. Darji says.
And people over 65 may also experience urinary incontinence, nighttime urination or confusion with a UTI, Dr. Tariq says. It can be easy to chalk bladder leaks up to aging or blame brain fog for confusion—but be sure to talk to your doctor, especially if you're also experiencing other UTI symptoms.
If you think you may have a urinary tract infection, an over-the-counter test may be able to confirm your suspicions. But if the test comes up negative and you're still experiencing UTI symptoms, let your doctor know anyway. 'OTC test strips can help as an initial screen, but they can miss infections or give false positives,' Dr. Darji says. 'They don't replace a medical evaluation. If symptoms persist or worsen, always see your doctor.'
And of course if you notice signs of a serious infection, head to urgent care. 'Red flag symptoms that require urgent care include fevers, chills, nausea, vomiting, severe back pain or generally feeling weak or ill,' Dr. Darji says.
If your doctor prescribes an antibiotic to clear up your UTI, be sure to take it as prescribed. 'In addition to antibiotics, people should drink plenty of water to help flush bacteria from the urinary tract,' Dr. Darji says. 'Avoid bladder irritants like caffeine, alcohol, spicy foods and artificial sweeteners until the infection clears.'
Sometimes it can take a few days for antibiotics to really kick in and start to provide noticeable relief from UTI symptoms. If your symptoms are causing serious discomfort, an over-the-counter pain reliever like phenazopyridine may help to relieve pain and burning from a UTI, Dr. Tariq says.
You may also want to try sipping unsweetened cranberry juice. While there's no conclusive evidence that it'll clear up a UTI you already have, research published in The Cochrane Database of Systematic Reviews suggests that cranberry juice and cranberry supplements may reduce the risk of recurring UTIs.
Want to read more health stories? Keep scrolling!
Why Do I Feel Like I Have to Pee But Can't? Common Causes and Simple Home Remedies
How To Tell if Your Pelvic Floor Is Tight or Weak—and Why Kegels Aren't Always the Answer
Your Sleep Position May Be Causing Bladder Leaks: How to Protect Your Pelvic Floor Health
This content is not a substitute for professional medical advice or diagnosis. Always consult your physician before pursuing any treatment plan.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
28 minutes ago
- Yahoo
POP Launches Canine Health Study with Innovative Pet Lab and Embark to Advance Data-Driven Pet Wellness
New U.S.-based study will explore the impact of gut-focused nutrition, DNA insights, and activity tracking on canine immunity and long-term vitality HOUSTON, Aug. 14, 2025 /PRNewswire/ -- Pet wellness company POP today announced the launch of a 90-day canine health study in collaboration with Innovative Pet Lab, and Embark Veterinary. Designed to explore how personalized nutrition, biological data, and behavior tracking can support immune health and long-term vitality, the study will enroll up to 100 dogs from across the United States. Participants will receive over $600 in free health tools, including POP's science-backed supplement POP-Topper, Innovative Pet Lab's gut biomarker test kits, and Embark's DNA test. The study will also deliver a personalized health report at the end of the 90 days, combining insights from multiple data sources. "Dogs can't always tell us when something's off—but their biology and behavior can," said Alan Tsui, Co-Founder of POP. "We're combining cutting-edge diagnostics, personalized nutrition, and real-world data to give pet parents a clearer picture of their dog's health—and contribute to a future where all dogs live longer, healthier lives." POP, short for "Power of Pets," launched in 2024 to address the growing need for preventative pet health solutions rooted in science and personalization. Its flagship product, POP-Topper, is a functional food topper formulated with clinically studied ingredients that support gut health and reduce inflammation. Innovative Pet Lab will provide two at-home gut health test kits per participant to measure key markers like calprotectin, zonulin, and SIgA. Embark Veterinary, the global leader in dog DNA testing, will offer breed, trait, and genetic risk profiling to support individualized interpretation. This comprehensive study will investigate how a personalized protocol—combining diet, gut diagnostics, DNA, and behavior data—can inform smarter, more proactive dog care. Results will also contribute to future research on the early detection and prevention of chronic diseases like IBD, arthritis, and obesity. Enrollment is now open for dog owners in the U.S. with dogs aged 1–6 years. Participants must commit to feeding POP-Topper daily, submitting samples, and completing a series of surveys and weekly logs. Those who complete the study will receive a full refund of their $99 deposit. To learn more or apply, visit: About POPPOP (Power of Pets) is a next-generation pet health company dedicated to extending canine healthspan—the years dogs spend thriving, not just surviving. POP combines science-backed supplements and personalized diagnostics to help pet parents make better health decisions. Learn more at About Innovative Pet LabInnovative Pet Lab is a leader in canine gut health screening tests. Their at-home testing kits translate microbiome and immune biomarkers into actionable insights, empowering earlier intervention and improved long-term outcomes for dogs. About Embark VeterinaryEmbark offers the most comprehensive dog DNA test on the market. Developed by veterinarians and geneticists, Embark provides breed breakdowns, health risk screening, and trait insights to support proactive care. View original content to download multimedia: SOURCE POP LABS (Pet Longevity Research Limited) Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Medscape
29 minutes ago
- Medscape
FDA Panel Seeks More Data on Filler Use in Decolletage Area
A FDA advisory panel recommended that manufacturers of dermal fillers collect more information on use in the decolletage area of the body and said that some patients might be at higher risk of complications from injections because of the proximity to breast tissue. The FDA has not approved dermal fillers for use in the decolletage — a body area that advisory panel members said was not well-defined. It is generally considered the triangular area that runs from the neck and clavicle area to in between the breasts. Agency officials and committee members noted that fillers are increasingly being used off-label to improve skin texture, crepiness, skin thickness, fine lines, and wrinkles in the decolletage. The most common fillers used in the neck and decolletage are made up of hyaluronic acid (HA), calcium hydroxylapatite (CaHA), or poly-L-lactic acid (PLLA), according to the American Academy of Dermatology Association (AADA). At a meeting on August 13, the FDA's General and Plastic Surgery Devices Panel was asked to review safety concerns, in anticipation that manufacturers will soon seek FDA approval of fillers for use in the decolletage area and need guidance on trial design and post-marketing studies. The agency raised the possibility that fillers could migrate from the injection site or form nodules and/or granulomas and interfere with mammograms, cause false positive readings on breast imaging or clinical exams, or impact breast feeding and lymphatic drainage. The committee — made up of dermatologists, plastic surgeons, oncologists, and radiologists — did not formally vote. The panel members agreed that patients who are breastfeeding or pregnant should be excluded from receiving injections because of the unknowns. Individuals with darker skin types or known wound-healing issues — both of whom might easily form keloids or nodules — or those with a history of radiotherapy, lymphoma, or other blood cancers were also seen as potentially higher risk populations, said panel chairman Hobart Harris, MD, MPH, the J. Engelbert Dunphy endowed chair in surgery at the University of California, San Francisco. Sandra R. Shuffett, MD, a breast imaging specialist in Lexington, Kentucky, and temporary panel member, said she was concerned that fillers could obscure tumors on breast imaging tests. 'My focus is to find a cancer as small as possible,' she said, adding that an unseen tumor could quickly grow larger, necessitating more serious treatment. The FDA has not received reports of problems with breast feeding or imaging but a post-approval study of Radiesse (CaHA) found that it obscured bone visualization. There have also been reports of lymph node enlargement near dermal filler injection sites. FDA reviewer Sung Yoon, MD, said at the meeting that the agency is 'not aware of specific reports where breast cancer was missed' because of dermal filler but noted that off-label use might mean less reporting of adverse events. Yoon told the panel that an analysis of the FDA's Medical Device Reporting database found 20 reports of serious injury events associated with the use of dermal fillers in the decolletage area since 2007 out of 186 reports related to unapproved upper body use. It is not possible to know how many decolletage procedures have been performed, she said. The FDA reported that an estimated 6.2 million dermal filler procedures were performed in 2024. Radiesse manufacturer, Merz Aesthetics, told the panel that, between 2018 and 2025, it received 44 reports of potential adverse events in the decolletage area, with none reporting migration of material or radiological interference. Radiesse is approved for decolletage wrinkles in the European Union and Canada. Social media may be fueling more use of fillers in the decolletage, especially among those taking GLP-1 receptor agonists for weight loss who are seeking 'to improve the skin rippling in the chest,' said Karol A. Gutowski, MD, a Chicago-based plastic surgeon who spoke to the committee. Representatives from dermatology and plastic surgery organizations said they had crafted guidelines for safe use of fillers in the decolletage but warned that filler use was often unregulated. 'Filler adverse events are likely under reported, and they're increasing in frequency as the popularity of injectable fillers increases,' said M. Laurin Council, MD, director of dermatologic surgery at Washington University School of Medicine, St. Louis, who spoke to the panel on behalf of the American Society for Dermatologic Surgery. Many panelists suggested women undergo baseline breast imaging before receiving filler in the decolletage area and collecting more data — such as on the volume of filler used during procedures — and added that perhaps a registry should be created. But some were skeptical. 'Probably 75% of these injections are done by non-medical people,' such as attendants at medical spas or storefront wellness centers, said panelist Alan Matarasso, MD, a New York City-based plastic surgeon and past president of the American Society of Plastic Surgeons. Matarasso said that manufacturers should be responsible for tracking their products, not clinicians. 'When these things are being done in strip malls and other places, we're not going to get the data that we need, because people are not going to cooperate with this,' said Gutowski. There is no approved method of removing dermal fillers. That gave some panel members pause. But dermatologists and plastic surgeons said that HA-based fillers could be dissolved with hyaluronidase. Even so, CaHA and PLLA fillers can't be dissolved and 'must break down naturally over time,' said Natalie Curcio, MD, MPH, a Nashville-based dermatologist who spoke to the panel on behalf of the AADA. Temporary committee member Karla V. Ballman, PhD, professor of biostatistics at the Mayo Clinic College of Medicine and Science, Rochester, Minnesota, said that patients should be informed, perhaps via wording on a product label that 'at the current time, there is no approved method of removal' of a filler. The FDA has periodically examined dermal filler safety. In July 2023, the agency updated its informational webpage to describe a new risk of delayed-onset inflammation near treatment sites that had been reported to occur following viral or bacterial illnesses or infections, vaccinations, or dental procedures. The webpage also lists common reactions such as bruising, redness, swelling, and pain. At the panel meeting, consumer advocate Diana Zuckerman, PhD, president of the National Center for Health Research, said that listing adverse events was not enough. 'Risks should be quantified with meaningful statistical data on the short term and long term risks,' said Zuckerman, who spoke during the open public hearing. 'FDA should require well designed and full clinical trials so that patients have the information they need to make informed decisions,' she said. 'FDA really appreciates the thoughtful discussion questions and recommendations that have been provided today, and we will certainly take all of these comments into consideration as we move forward,' said Cynthia Chang, PhD, an acting division director within the agency's Center for Devices and Radiological Health.


Medscape
29 minutes ago
- Medscape
Infographic: Millennial Doctors' Investment Comfort Zone
Millennial physicians (ages 28-43) feel most comfortable investing in mutual funds, individual stocks, and exchange-traded funds (ETFs). Those categories are also where they reported their best investment returns, a Medscape survey revealed. This infographic presents key insights from a new report on investment habits and preferences of younger doctors. To learn more, check out the Medscape Millennial Doctors Invest for the Future Report 2025. Medscape Millennial Doctors Invest for the Future Report 2025